These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 9629123)

  • 1. Clopidogrel for reduction of atherosclerotic events.
    Med Lett Drugs Ther; 1998 Jun; 40(1028):59-60. PubMed ID: 9629123
    [No Abstract]   [Full Text] [Related]  

  • 2. [Diagnosis, causes, relevance of a complex phenomenon. Resistance to aspirin and clopidogrel].
    Mani H; Lindhoff-Last E
    Pharm Unserer Zeit; 2009; 38(4):342-50. PubMed ID: 19572355
    [No Abstract]   [Full Text] [Related]  

  • 3. [Technological and biopharmaceutical aspects. Antiplatelet agents for oral administration].
    Breitkreutz J
    Pharm Unserer Zeit; 2009; 38(4):330-7. PubMed ID: 19572353
    [No Abstract]   [Full Text] [Related]  

  • 4. Absorption, metabolization, and antiplatelet effects of 300-, 600-, and 900-mg loading doses of clopidogrel: results of the ISAR-CHOICE (Intracoronary Stenting and Antithrombotic Regimen: Choose Between 3 High Oral Doses for Immediate Clopidogrel Effect) Trial.
    von Beckerath N; Taubert D; Pogatsa-Murray G; Schömig E; Kastrati A; Schömig A
    Circulation; 2005 Nov; 112(19):2946-50. PubMed ID: 16260639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variability of response to clopidogrel: possible mechanisms and clinical implications.
    Nguyen T; Frishman WH; Nawarskas J; Lerner RG
    Cardiol Rev; 2006; 14(3):136-42. PubMed ID: 16628022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clopidogrel and proton pump inhibitors--boon or bane?].
    Labenz J; Meyners W; Petersen KU
    Dtsch Med Wochenschr; 2010 Feb; 135(5):203-6. PubMed ID: 20104441
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clopidogrel protection is not increased further by ASS!].
    Bogousslavsky J
    Praxis (Bern 1994); 2004 Aug; 93(35):1390. PubMed ID: 15468578
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clopidogrel as basic therapy in high-risk stroke patients].
    Mattle HP
    Praxis (Bern 1994); 2004 Aug; 93(34):1364. PubMed ID: 15468694
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clopidogrel and aspirin versus aspirin alone in prevention of atherothrombotic events. The results of CHARISMA study].
    Gaciong Z
    Kardiol Pol; 2006 May; 64(5):548-51; discussion 551-2. PubMed ID: 16752345
    [No Abstract]   [Full Text] [Related]  

  • 10. Optimizing platelet P2Y12 inhibition for patients undergoing PCI.
    Steinhubl S; Roe MT
    Cardiovasc Drug Rev; 2007; 25(2):188-203. PubMed ID: 17614940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using clopidogrel bisulfate: a new antiplatelet drug.
    Pfister SM
    Nurse Pract; 1999 Sep; 24(9):100-1, 105-8, 110. PubMed ID: 10507077
    [No Abstract]   [Full Text] [Related]  

  • 12. Clopidogrel: a new antiplatelet drug.
    Lerner RG; Frishman WH; Mohan KT
    Heart Dis; 2000; 2(2):168-73. PubMed ID: 11728254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clopidogrel: new indication. In combination with aspirin: marginal additional benefits.
    Prescrire Int; 2007 Aug; 16(90):146. PubMed ID: 17724837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atorvastatin does not affect the antiplatelet potency of clopidogrel when it is administered concomitantly for 5 weeks in patients with acute coronary syndromes.
    Mitsios JV; Papathanasiou AI; Rodis FI; Elisaf M; Goudevenos JA; Tselepis AD
    Circulation; 2004 Mar; 109(11):1335-8. PubMed ID: 15023882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clopidogrel in interventional cardiology: questions answered and questions remaining.
    Nikhil JY; Radhakrishnan S; Paradiso-Hardy FL; Cohen EA
    Can J Cardiol; 2002 Jul; 18(7):739-48. PubMed ID: 12167961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time dependence of platelet inhibition after a 600-mg loading dose of clopidogrel in a large, unselected cohort of candidates for percutaneous coronary intervention.
    Hochholzer W; Trenk D; Frundi D; Blanke P; Fischer B; Andris K; Bestehorn HP; Büttner HJ; Neumann FJ
    Circulation; 2005 May; 111(20):2560-4. PubMed ID: 15809367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clopidogrel. Actions, pharmacokinetics, clinical studies].
    Wunderlich H; Beer J; Allgaier C
    Med Monatsschr Pharm; 2002 Dec; 25(12):425-9. PubMed ID: 12522913
    [No Abstract]   [Full Text] [Related]  

  • 18. Personalized medicine, pharmacogenetics, and clopidogrel: unraveling variability of response.
    Rocca B; Petrucci G
    Mol Interv; 2010 Feb; 10(1):12-9. PubMed ID: 20124559
    [No Abstract]   [Full Text] [Related]  

  • 19. Repeated-dose pharmacodynamics of clopidogrel in healthy subjects.
    Thebault JJ; Kieffer G; Lowe GD; Nimmo WS; Cariou R
    Semin Thromb Hemost; 1999; 25 Suppl 2():9-14. PubMed ID: 10440416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clopidogrel and the CURE results.
    Maggioni AP
    Haematologica; 2001 Nov; 86(11 Suppl 2):40. PubMed ID: 11926775
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.